Faculty

Julia Lea Ziegengeist, PharmD, BCOP (Moderator)

Clinical Pharmacist Specialist, 
Breast Medical Oncology, Pharmacy Services 
Levine Cancer, Barbara L. Levine Oncology Breast & Cutaneous Center
Charlotte, NC

Dr. Julia Ziegengeist practices as a Clinical Pharmacist Specialist for solid tumor oncology specializing in breast cancer at Atrium Health Levine Cancer in Charlotte, North Carolina. She completed her PGY-1 Pharmacy Residency and PGY-2 Oncology Pharmacy Residency at Virginia Commonwealth University in Richmond, Virginia in 2018 and 2019, respectively. Since completion of residency, her primary oncology practice site has been within the Levine Cancer Institute Breast Medical Oncology Clinic, where she works alongside providers and APPs to ensure quality cancer care by tailoring treatment options and subsequent toxicity management to individual patients. She is a board-certified oncology pharmacist and her professional interests include patient education, toxicity management, and expansion of clinical pharmacy services within oncology.

Jaelyn Sanchez (Speaker)

PharmD Candidate, Class of 2026
Texas Tech University Health Sciences Center
Dallas, TX

Jaelyn Sanchez recently graduated with her PharmD from Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy in Dallas, Texas. She was born and raised in New Mexico and earned her bachelor’s degree in biology from New Mexico State University. Her interest in becoming a pharmacist was inspired by her older brother, Jason, who is also a pharmacist. 

During pharmacy school, Jaelyn developed an interest in oncology after learning from clinical oncology pharmacist and professor Chris Selby. Her clinical interests continued to grow through hospital internship and clinical rotation experiences. Jaelyn recently matched with the Carolinas Medical Center PGY1 Pharmacy Residency Program, where she looks forward to continuing to grow as a clinical pharmacist and advancing compassionate, evidence-based patient care.

Nora Abifaraj (Speaker)

Doctor of Pharmacy Candidate 2026
The University of Texas at Austin, 
College of Pharmacy
Austin, TX

Nora Abifaraj is a current PharmD Graduate, Class of 2026 from the University of Texas at Austin College of Pharmacy. She is an Incoming PGY-1 Resident at Memorial Hermann - TMC. 

Program Planners

Julia Lea Ziegengeist, PharmD, BCOP

Clinical Pharmacist Specialist, 
Breast Medical Oncology, Pharmacy Services 
Levine Cancer, Barbara L. Levine Oncology Breast & Cutaneous Center
Charlotte, NC

Dr. Julia Ziegengeist practices as a Clinical Pharmacist Specialist for solid tumor oncology specializing in breast cancer at Atrium Health Levine Cancer in Charlotte, North Carolina. She completed her PGY-1 Pharmacy Residency and PGY-2 Oncology Pharmacy Residency at Virginia Commonwealth University in Richmond, Virginia in 2018 and 2019, respectively. Since completion of residency, her primary oncology practice site has been within the Levine Cancer Institute Breast Medical Oncology Clinic, where she works alongside providers and APPs to ensure quality cancer care by tailoring treatment options and subsequent toxicity management to individual patients. She is a board-certified oncology pharmacist and her professional interests include patient education, toxicity management, and expansion of clinical pharmacy services within oncology.

Marshall Winget, PharmD, BCOP

Inpatient Clinical Pharmacist
Malignant Hematology/Bone Marrow Transplant
Duke University Hospital, Durham
Durham, NC

Marshall Winget is a malignant hematology inpatient clinical pharmacist at Duke University Hospital. He earned his undergraduate degree from the University of Minnesota and his Doctor of Pharmacy from the University of North Carolina Eshelman School of Pharmacy. He then completed his PGY1 Pharmacy Practice Residency and PGY2 Oncology Pharmacy Residency at Vanderbilt University Medical Center in Nashville, Tennessee. His professional interests and research focus on lymphomas, cellular therapies, and cardio-oncology.

Disclosures

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Planners

*Horizon CME has mitigated and resolved all relevant financial relationships

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Other Contributors

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.